Document is current
Any future updates will be listed below
-
Authors
Ono, Andre Hideo
Moura, Thiago Rocha
Govêia, Cátia Sousa
Guimarães, Gabriel Magalhães Nunes https://orcid.org/0000-0001-6289-2233
de Araújo Ladeira, Luís Cláudio
da Silva, Helga Bezerra Gomes
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02454868 at ClinicalTrials.govDocuments that mention this clinical trial
ED50 of remifentanil for providing excellent intubating conditions when co-administered with a single standard dose of propofol without the use of muscle relaxants in children: dose-finding clinical trial
https://doi.org/10.1007/s00540-018-2502-z
- License Information
-
More Information
Article History
Received: 3 February 2018
Accepted: 27 April 2018
First Online: 4 May 2018
Compliance with ethical standards
:
: Gabriel Magalhães Nunes Guimarães received funds from Pfizer in 2017 for writing a review about COX-2 drugs. The other authors declare no significant conflicts of interest.
: Registry name: Clinical Trials. Date the trial was registered: May, 27, 2015. Date the first participant was enrolled: July, 4, 2016. URL of the registry: . Trial registration number: NCT02454868. Trial registration name: Remifentanil Minimum Effective Dose for Children Intubation Without Neuromuscular Blockade.
